Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction
- PMID: 22796148
- DOI: 10.1016/j.freeradbiomed.2012.06.041
Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction
Abstract
Facioscapulohumeral muscular dystrophy (FSHD), the most frequent muscular dystrophy, is an autosomal dominant disease. In most individuals with FSHD, symptoms are restricted to muscles of the face, arms, legs, and trunk. FSHD is genetically linked to contractions of the D4Z4 repeat array causing activation of several genes. One of these maps in the repeat itself and expresses the DUX4 (the double homeobox 4) transcription factor causing a gene deregulation cascade. In addition, analyses of the RNA or protein expression profiles in muscle have indicated deregulations in the oxidative stress response. Since oxidative stress affects peripheral muscle function, we investigated mitochondrial function and oxidative stress in skeletal muscle biopsies and blood samples from patients with FSHD and age-matched healthy controls, and evaluated their association with physical performances. We show that specifically, oxidative stress (lipid peroxidation and protein carbonylation), oxidative damage (lipofuscin accumulation), and antioxidant enzymes (catalase, copper-zinc-dependent superoxide dismutase, and glutathione reductase) were higher in FSHD than in control muscles. FSHD muscles also presented abnormal mitochondrial function (decreased cytochrome c oxidase activity and reduced ATP synthesis). In addition, the ratio between reduced (GSH) and oxidized glutathione (GSSG) was strongly decreased in all FSHD blood samples as a consequence of GSSG accumulation. Patients with FSHD also had reduced systemic antioxidative response molecules, such as low levels of zinc (a SOD cofactor), selenium (a GPx cofactor involved in the elimination of lipid peroxides), and vitamin C. Half of them had a low ratio of gamma/alpha tocopherol and higher ferritin concentrations. Both systemic oxidative stress and mitochondrial dysfunction were correlated with functional muscle impairment. Mitochondrial ATP production was significantly correlated with both quadriceps endurance (T(LimQ)) and maximal voluntary contraction (MVC(Q)) values (rho=0.79, P=0.003; rho=0.62, P=0.05, respectively). The plasma concentration of oxidized glutathione was negatively correlated with the T(LimQ), MVC(Q) values, and the 2-min walk distance (MWT) values (rho=-0.60, P=0.03; rho=-0.56, P=0.04; rho=-0.93, P<0.0001, respectively). Our data characterized oxidative stress in patients with FSHD and demonstrated a correlation with their peripheral skeletal muscle dysfunction. They suggest that antioxidants that might modulate or delay oxidative insult may be useful in maintaining FSHD muscle functions.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial.Free Radic Biol Med. 2015 Apr;81:158-69. doi: 10.1016/j.freeradbiomed.2014.09.014. Epub 2014 Sep 20. Free Radic Biol Med. 2015. PMID: 25246239 Clinical Trial.
-
RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.Acta Neurol Scand. 2007 Feb;115(2):115-21. doi: 10.1111/j.1600-0404.2006.00724.x. Acta Neurol Scand. 2007. PMID: 17212615
-
Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target.Redox Biol. 2022 May;51:102251. doi: 10.1016/j.redox.2022.102251. Epub 2022 Jan 29. Redox Biol. 2022. PMID: 35248827 Free PMC article.
-
Facioscapulohumeral muscular dystrophy: do neurotrophins play a role?Muscle Nerve. 2010 Jan;41(1):120-7. doi: 10.1002/mus.21505. Muscle Nerve. 2010. PMID: 19813193 Review.
-
DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy.Cells. 2021 Nov 26;10(12):3322. doi: 10.3390/cells10123322. Cells. 2021. PMID: 34943834 Free PMC article. Review.
Cited by
-
Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy.Int J Mol Sci. 2020 Aug 4;21(15):5575. doi: 10.3390/ijms21155575. Int J Mol Sci. 2020. PMID: 32759720 Free PMC article.
-
High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity.Skelet Muscle. 2014 Feb 1;4(1):4. doi: 10.1186/2044-5040-4-4. Skelet Muscle. 2014. PMID: 24484587 Free PMC article.
-
PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle.Nat Commun. 2017 Dec 18;8(1):2152. doi: 10.1038/s41467-017-01200-4. Nat Commun. 2017. PMID: 29255294 Free PMC article.
-
Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy.Hum Mol Genet. 2024 May 4;33(10):872-883. doi: 10.1093/hmg/ddae019. Hum Mol Genet. 2024. PMID: 38340007 Free PMC article.
-
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update.Orphanet J Rare Dis. 2021 Mar 12;16(1):129. doi: 10.1186/s13023-021-01760-1. Orphanet J Rare Dis. 2021. PMID: 33712050 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials